For Patients
The National Comprehensive Cancer Network is an alliance of 21 of the world’s leading cancer centers, working together to develop treatment guidelines for most cancers, and dedicated to research that improves the quality, effectiveness and efficiency of cancer care. NCCN offers a number of programs to help you and your family make informed decisions about your health.
The Growing Cancer Burden
Today, lifetime cancer risk in the United States is 1 in 2 for men and 1 in 3 for women, with approximately 1.44 million new cases of cancer expected to develop in 2007 alone. Cancer still accounts for 1 in 4 deaths, with more than 559,650 people expected to die from their cancer in 2007.
Cancer clinical trials are research studies to find better ways to treat cancer. Clinical trials often compare the most accepted cancer treatment (standard treatment) with a new treatment that doctors hope will be better. What doctors learn in these trials will help people with cancer-now and in the future.
NCCN is committed to improving and advancing promising cancer therapies through clinical trials. NCCN’s Oncology Research Program (ORP) supports research at NCCN Member Institutions and facilitates the post-approval evaluation of innovative and promising therapies.
The NCCN and the American Cancer Society™ (ACS) have partnered to translate the NCCN Clinical Practice Guidelines in Oncology™ into a patient-friendly resource outlining appropriate treatment. These guidelines offer patients with cancer and their families reliable information to help them work with their physicians to make timely and well-informed decisions about their care.
The NCCN Physician Directory is a comprehensive listing of physicians and their specialties located at our 21 NCCN Member Institutions. Although this is an extensive listing, it is not complete. If you would like more information on a particular physician or NCCN institution, you may contact the institution's Physician Referral Department.
The information on this website is provided as a public service by the National Comprehensive Cancer Network (NCCN). Links to other sites contained herein, including references to specific products, processes or services does not constitute or imply a recommendation or endorsement by the NCCN.
NCCN News includes all the latest announcements about NCCN programs, educational materials and upcoming events as well as recent press coverage.
NCCN scientists and other researchers around the globe continue to unravel the human genetic code. Their discoveries hold great promise, and may eventually allow for targeted biological and gene therapy. Research is beginning to make it possible to estimate predisposition to specific cancers, through identification of genetic mutations in individuals at high-risk for cancer. Visit our NCCN Member Institutions to learn more about their genetic counseling, testing, and screening programs.
Facing a serious illness is difficult enough for adults, but when the patient is a child there is an even more urgent need for information, compassion, sensitivity, and care. NCCN Member Institutions treat approximately 30% of the pediatric cancer cases in this country. From Nobel Prize winners to directors of national pediatric clinical cooperative groups, NCCN pediatric oncologists lead the way in caring for children with cancer. Visit our NCCN Member Institutions to learn more about their pediatric oncology programs.
|